No Data
No Data
No Data
No Data
No Data
Erasca (ERAS) Upgraded to Strong Buy: What Does It Mean for the Stock?
Yahoo FinanceApr 24 00:00
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersChromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. The company's market cap stands at $8.7 million. Kineta (NASDAQ:KA) stock moved upwards
BenzingaApr 19 20:08
Erasca's Promising Naporafenib Data and Financial Stability Merit a Buy Rating
TipRanksApr 3 13:47
Erasca Is Maintained at Buy by Goldman Sachs
Erasca Is Maintained at Buy by Goldman Sachs
Dow JonesApr 3 00:41
Goldman Sachs Maintains Buy on Erasca, Raises Price Target to $7
Goldman Sachs analyst Chris Shibutani maintains Erasca with a Buy and raises the price target from $6 to $7.
Analyst UpgradesApr 3 00:16
Erasca, Inc. (NASDAQ:ERAS) Q4 2023 Earnings Call Transcript
Yahoo FinanceApr 2 04:56
No Data
No Data